神經退化性疾病治療藥的全球市場:2022年～2026年

全球神經退化性疾病治療藥的市場規模在2022年～2026年間，預測將成長到197億4,000萬美元，在預測期間內預計將以7.98％的年複合成長率增長。

市場成長的主要因素有強大的藥物開發渠道、廣泛的神經退行性疾​​病研究資金以及敏感診斷方式的可用性等。

本報告涵括神經退化性疾病治療藥的全球市場的整體分析，提供市場規模與預測，趨勢，成長要素，課題，及約25供應商的分析。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 2021年的市場規模
• 市場預測:從2021年～2026年的預測

第4章 波特的五力分析

• 五力彙整
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第5章 市場區隔:各適應症

• 市場區隔
• 各適應症的比較
• 多發性硬化症:市場規模與預測(2021年～2026年)
• 阿茲海默症:市場規模與預測(2021年～2026年)
• 帕金森氏症:市場規模與預測(2021年～2026年)
• 亨丁頓舞蹈症:市場規模與預測(2021年～2026年)
• 其他：市場規模與預測(2021年～2026年)
• 各適應症的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區市場區隔
• 各地區的比較
• 北美:市場規模與預測(2021年～2026年)
• 歐洲:市場規模與預測(2021年～2026年)
• 亞洲:市場規模與預測(2021年～2026年)
• 其他地區:市場規模與預測(2021年～2026年)
• 美國:市場規模與預測(2021年～2026年)
• 加拿大:市場規模與預測(2021年～2026年)
• 英國:市場規模與預測(2021年～2026年)
• 德國:市場規模與預測(2021年～2026年)
• 日本:市場規模與預測(2021年～2026年)
• 中國:市場規模與預測(2021年～2026年)
• 各地區的市場機會

第8章 推動要素，課題，及趨勢

• 市場推動要素
• 市場課題
• 推動要素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• AB Science SA
• AbbVie Inc.
• Acadia Pharmaceuticals Inc.
• Biogen Inc.
• F. Hoffmann La Roche Ltd.
• H Lundbeck AS
• Mitsubishi Chemical Holdings Corp.
• Novartis AG
• Sanofi
• Teva Pharmaceutical Industries Ltd.

第11章 附錄

• 調查範圍
• 包含與排除清單
• US$的匯率
• 調查手法
• 簡稱的清單

Technavio has been monitoring the neurodegenerative diseases therapeutics market and it is poised to grow by $ 19.74 bn during 2022-2026, accelerating at a CAGR of 7.98% during the forecast period. Our report on the neurodegenerative diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a strong drug development pipeline, high research funding on neurodegenerative diseases, and the availability of highly sensitive diagnostic modalities.

The neurodegenerative diseases therapeutics market analysis includes indication segment and geographic landscape.

Technavio's neurodegenerative diseases therapeutics market is segmented as below:

By indication

• Multiple sclerosis
• Alzheimers disease
• Parkinsons disease
• Huntingtons disease
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in the aging population as one of the prime reasons driving the neurodegenerative diseases therapeutics market growth during the next few years. Also, an improved understanding of the genetic basis and molecular pathology of neurodegenerative diseases and a high economic burden will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the neurodegenerative diseases therapeutics market covers the following areas:

• Neurodegenerative diseases therapeutics market sizing
• Neurodegenerative diseases therapeutics market forecast
• Neurodegenerative diseases therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodegenerative diseases therapeutics market vendors that include AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., Biogen Inc., F. Hoffmann La Roche Ltd., H Lundbeck AS, Mitsubishi Chemical Holdings Corp., Novartis AG, Sanofi, and Teva Pharmaceutical Industries Ltd. Also, the neurodegenerative diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Indication

• 5.1 Market segments
• Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
• 5.2 Comparison by Indication
• Exhibit 26: Chart on Comparison by Indication
• Exhibit 27: Data Table on Comparison by Indication
• 5.3 Multiple sclerosis - Market size and forecast 2021-2026
• Exhibit 28: Chart on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
• 5.4 Alzheimers disease - Market size and forecast 2021-2026
• Exhibit 32: Chart on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Alzheimers disease - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Alzheimers disease - Year-over-year growth 2021-2026 (%)
• 5.5 Parkinsons disease - Market size and forecast 2021-2026
• Exhibit 36: Chart on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Parkinsons disease - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Parkinsons disease - Year-over-year growth 2021-2026 (%)
• 5.6 Huntingtons disease - Market size and forecast 2021-2026
• Exhibit 40: Chart on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Huntingtons disease - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Huntingtons disease - Year-over-year growth 2021-2026 (%)
• 5.7 Others - Market size and forecast 2021-2026
• Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
• 5.8 Market opportunity by Indication
• Exhibit 48: Market opportunity by Indication ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 50: Chart on Market share by geography 2021-2026 (%)
• Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 52: Chart on Geographic comparison
• Exhibit 53: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 Germany - Market size and forecast 2021-2026
• Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.11 Japan - Market size and forecast 2021-2026
• Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
• 7.12 China - Market size and forecast 2021-2026
• Exhibit 90: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 91: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 92: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 93: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.13 Market opportunity by geography
• Exhibit 94: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 95: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 96: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 97: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 98: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 99: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 100: Matrix on vendor position and classification
• 10.3 AB Science SA
• Exhibit 101: AB Science SA - Overview
• Exhibit 102: AB Science SA - Product / Service
• Exhibit 103: AB Science SA - Key offerings
• 10.4 AbbVie Inc.
• Exhibit 104: AbbVie Inc. - Overview
• Exhibit 105: AbbVie Inc. - Product / Service
• Exhibit 106: AbbVie Inc. - Key offerings
• 10.5 Acadia Pharmaceuticals Inc.
• Exhibit 107: Acadia Pharmaceuticals Inc. - Overview
• Exhibit 108: Acadia Pharmaceuticals Inc. - Product / Service
• Exhibit 109: Acadia Pharmaceuticals Inc. - Key offerings
• 10.6 Biogen Inc.
• Exhibit 110: Biogen Inc. - Overview
• Exhibit 111: Biogen Inc. - Product / Service
• Exhibit 112: Biogen Inc. - Key offerings
• 10.7 F. Hoffmann La Roche Ltd.
• Exhibit 113: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 114: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 115: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 116: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 117: F. Hoffmann La Roche Ltd. - Segment focus
• 10.8 H Lundbeck AS
• Exhibit 118: H Lundbeck AS - Overview
• Exhibit 119: H Lundbeck AS - Product / Service
• Exhibit 120: H Lundbeck AS - Key offerings
• 10.9 Mitsubishi Chemical Holdings Corp.
• Exhibit 121: Mitsubishi Chemical Holdings Corp. - Overview
• Exhibit 122: Mitsubishi Chemical Holdings Corp. - Business segments
• Exhibit 123: Mitsubishi Chemical Holdings Corp. - Key offerings
• Exhibit 124: Mitsubishi Chemical Holdings Corp. - Segment focus
• 10.10 Novartis AG
• Exhibit 125: Novartis AG - Overview
• Exhibit 126: Novartis AG - Business segments
• Exhibit 127: Novartis AG - Key offerings
• Exhibit 128: Novartis AG - Segment focus
• 10.11 Sanofi
• Exhibit 129: Sanofi - Overview
• Exhibit 130: Sanofi - Business segments
• Exhibit 131: Sanofi - Key news
• Exhibit 132: Sanofi - Key offerings
• Exhibit 133: Sanofi - Segment focus
• 10.12 Teva Pharmaceutical Industries Ltd.
• Exhibit 134: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 135: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 136: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 137: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 138: Teva Pharmaceutical Industries Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 139: Inclusions checklist
• Exhibit 140: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 141: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 142: Research methodology
• Exhibit 143: Validation techniques employed for market sizing
• Exhibit 144: Information sources
• 11.5 List of abbreviations
• Exhibit 145: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Indication - Market share 2021-2026 (%)
• Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Indication
• Exhibits27: Data Table on Comparison by Indication
• Exhibits28: Chart on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Multiple sclerosis - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Multiple sclerosis - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Alzheimers disease - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Alzheimers disease - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Alzheimers disease - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Parkinsons disease - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Parkinsons disease - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Parkinsons disease - Year-over-year growth 2021-2026 (%)
• Exhibits40: Chart on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
• Exhibits41: Data Table on Huntingtons disease - Market size and forecast 2021-2026 ($ million)
• Exhibits42: Chart on Huntingtons disease - Year-over-year growth 2021-2026 (%)
• Exhibits43: Data Table on Huntingtons disease - Year-over-year growth 2021-2026 (%)
• Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
• Exhibits48: Market opportunity by Indication ($ million)
• Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits50: Chart on Market share by geography 2021-2026 (%)
• Exhibits51: Data Table on Market share by geography 2021-2026 (%)
• Exhibits52: Chart on Geographic comparison
• Exhibits53: Data Table on Geographic comparison
• Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits84: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibits87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibits88: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibits89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
• Exhibits90: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits91: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits92: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits93: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits94: Market opportunity by geography ($ million)
• Exhibits95: Impact of drivers and challenges in 2021 and 2026
• Exhibits96: Overview on Criticality of inputs and Factors of differentiation
• Exhibits97: Overview on factors of disruption
• Exhibits98: Impact of key risks on business
• Exhibits99: Vendors covered
• Exhibits100: Matrix on vendor position and classification
• Exhibits101: AB Science SA - Overview
• Exhibits102: AB Science SA - Product / Service
• Exhibits103: AB Science SA - Key offerings
• Exhibits104: AbbVie Inc. - Overview
• Exhibits105: AbbVie Inc. - Product / Service
• Exhibits106: AbbVie Inc. - Key offerings
• Exhibits107: Acadia Pharmaceuticals Inc. - Overview
• Exhibits108: Acadia Pharmaceuticals Inc. - Product / Service
• Exhibits109: Acadia Pharmaceuticals Inc. - Key offerings
• Exhibits110: Biogen Inc. - Overview
• Exhibits111: Biogen Inc. - Product / Service
• Exhibits112: Biogen Inc. - Key offerings
• Exhibits113: F. Hoffmann La Roche Ltd. - Overview
• Exhibits114: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits115: F. Hoffmann La Roche Ltd. - Key news
• Exhibits116: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits117: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits118: H Lundbeck AS - Overview
• Exhibits119: H Lundbeck AS - Product / Service
• Exhibits120: H Lundbeck AS - Key offerings
• Exhibits121: Mitsubishi Chemical Holdings Corp. - Overview
• Exhibits122: Mitsubishi Chemical Holdings Corp. - Business segments
• Exhibits123: Mitsubishi Chemical Holdings Corp. - Key offerings
• Exhibits124: Mitsubishi Chemical Holdings Corp. - Segment focus
• Exhibits125: Novartis AG - Overview
• Exhibits126: Novartis AG - Business segments
• Exhibits127: Novartis AG - Key offerings
• Exhibits128: Novartis AG - Segment focus
• Exhibits129: Sanofi - Overview
• Exhibits130: Sanofi - Business segments
• Exhibits131: Sanofi - Key news
• Exhibits132: Sanofi - Key offerings
• Exhibits133: Sanofi - Segment focus
• Exhibits134: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits135: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits136: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits137: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits138: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits139: Inclusions checklist
• Exhibits140: Exclusions checklist
• Exhibits141: Currency conversion rates for US$
• Exhibits142: Research methodology
• Exhibits143: Validation techniques employed for market sizing
• Exhibits144: Information sources
• Exhibits145: List of abbreviations